SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-07
👔
Immunome Inc.
@IMNM_InsiderForm 4 Filing: Lechleider Robert Sells $1.7M of $IMNM
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Immunome Inc.
Ticker: $IMNM
Transaction Value
$1.7M
Price/Share: $15.68
transaction date
2026-07-02
Shares: 110,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Lechleider Robert, holds the title of Chief Medical Officer at Immunome Inc..
On 2026-07-02, the insider transacted 110,000 shares.The shares were transacted at a weighted average price of $15.68 per share, resulting in a total market-relevant value of $1.7M.
Executive Summary Summary
Lechleider Robert (Chief Medical Officer) sold $1.7M of $IMNM
Post-Transaction Position: 48,091 shares
SEC Accession No: 0001997584-26-000004 (CIK: 1997584)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.